Cerebellum and Cortical Plasticity: the Case of Dystonia (CERDYS)
Primary Purpose
Dystonia
Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Transcranial magnetic stimulation
Sponsored by
About this trial
This is an interventional basic science trial for Dystonia focused on measuring Cerebellum, Cortical plasticity, Sensorimotor adaptation, Dystonia, Cerebral Palsy, Transcranial Magnetic Stimulation, and
Eligibility Criteria
Inclusion criteria
All subjects
- Age >18 years and < 70 years
- Normal physical and neurological examination, except for dystonia (when present)
- No treatment with botulinum toxin during the last three months
- No treatment altering the cortical excitability
- Agreement to use a medically acceptable method of contraception throughout the study for female of childbearing potential
Primary focal dystonia group
- Patients with cervical and/or upper limb dystonia
- No cause of secondary dystonia
Secondary dystonia group
• Cervical dystonia and/or upper limb dystonia History of perinatal anoxia
Exclusion criteria
- MMS ≤ 24/30
- Current neurological or psychiatric illness other than dystonia.
- Individual who is on medication which is known to lower seizure threshold (see lists above), or who has a pacemaker, an implanted medical pump, a metal plate, a metal plate or metal object in the skull or eye (for example after brain surgery) will be excluded
- Uncontrollable medical problems not related to dystonia such as; cardiopulmonary disease, severe rheumatoid arthritis, active joint deformity of arthritic origin, active cancer, or renal disease
- Previous history of seizure(s) or current active epilepsy
- Pregnancy, breast feeding women and women who are of childbearing age and not practicing adequate birth control.
- Patients legally protected
- Patients who are not enrolled at social security
Sites / Locations
- Hpôpital Pitié Sapétrière - U 975 Plate forme " Pole Exploration de l'homme : Gait, Equilibrium, Posture, and Movement "Recruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Experimental
Experimental
Other
Arm Label
Primary cervical dystonia Patients
Primary upperlimb Dystonia Patients
Secondary Cervical or Upperlimb Dystonia due to cerebral palsy
Healthy volunteers
Arm Description
Outcomes
Primary Outcome Measures
Comparison of MEP0/MEP10 and MEP0/MEP30 values obtained after sham, cRTBS or iTBS of the cerebellum.
The effect of rTMS induced modulation of the cerebellar output on the PAS induced plasticity will be assessed by measurement of the size variation of a 1mV test motor evoked potential (which reflect cortical excitability) before (MEP0) and 10 and 30 minutes (MEP10 and MEP30) after PAS. The primary outcome measure will be the comparison of MEP0/MEP10 and MEP0/MEP30 values obtained after sham, cRTBS or iTBS of the cerebellum.
Secondary Outcome Measures
Variation of the appropriate dystonic clinical score (depending on the type of dystonia) after each rTMS session (cTBS, iTBS, sham).
The effect of rTMS induced modulation of the cerebellar output on dystonic symptoms will be assessed by the variation of the appropriate dystonic clinical score (depending on the type of dystonia) after each rTMS session (cTBS, iTBS, sham).
Measurement of number of errors, mean time to reach the target after each rTMS session (cTBS, iTBS, sham).
The effect of rTMS induced modulation of the cerebellar output on the performance at the sensorimotor adaptation task will be assessed by measurement of number of errors, mean time to reach the target after each rTMS session (cTBS, iTBS, sham).
Measurement of the variation of the motor threshold, intracortical inhibition and intracortical facilitation after each rTMS session (cTBS, iTBS, sham).
The effect of rTMS induced modulation of the cerebellar output on other parameter reflecting cortical excitability will be assessed by measurement of the variation of the motor threshold, intracortical inhibition and intracortical facilitation after each rTMS session (cTBS, iTBS, sham).
Full Information
NCT ID
NCT01272154
First Posted
January 5, 2011
Last Updated
January 27, 2012
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Collaborators
Sree Chitra Tirunal Institute for Medical Sciences & Technology, Policlinico G . Martino, Messina Italy
1. Study Identification
Unique Protocol Identification Number
NCT01272154
Brief Title
Cerebellum and Cortical Plasticity: the Case of Dystonia
Acronym
CERDYS
Official Title
Cerebellum and Cortical Plasticity: the Case of Dystonia
Study Type
Interventional
2. Study Status
Record Verification Date
January 2012
Overall Recruitment Status
Unknown status
Study Start Date
January 2011 (undefined)
Primary Completion Date
January 2013 (Anticipated)
Study Completion Date
January 2014 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Collaborators
Sree Chitra Tirunal Institute for Medical Sciences & Technology, Policlinico G . Martino, Messina Italy
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Purpose
- Objective : Sensorimotor adaptation allows the modification of the motor command taking into account the errors detected during execution of prior movements. It involves a large cortico-subcortical network. Isolated lesions of this network do not systematically alter sensorimotor adaptation except for cerebellar lesions. The cerebellum is thus a key structure for sensorimotor adaptation. However, the link between cerebellar and the cortical plasticity underlying sensorimotor adaptation remain unknown. Alteration of sensorimotor adaptation is associated with dystonia but it is unclear whether it is a cause or consequence of dystonia. It has been hypothesized that the abnormal plasticity observed in dystonia could account for the associated alteration of sensorimotor adaptation.
Classically, basal ganglia dysfunction is considered to be crucial for dystonia pathogenesis. However, recent studies suggest that the involvement of the cerebellum may also be important in this setting. In primary dystonia, imaging studies showed abnormal cerebellar activation during sensorimotor adaptation tasks and neurophysiological studies demonstrated a decrease of cerebellar output.
The aim of this study is to investigate the role of the cerebellum in the cortical plasticity underlying sensorimotor adaptation both in healthy subjects (normal plasticity) and in dystonic patients (abnormal plasticity).
- Methods: Paired associative stimulation PAS consists in repetitive pairing of a peripheral nerve and a cortical stimulation. This kind of stimulation has been designed to induce artificial plasticity that can be easily measured. This PAS induced sensorimotor plasticity is exacerbated and has lost its topographical specificity in dystonic patients.TMS using trains of TMS pulses (rTMS) can be applied on the cerebellum to modulate its output. We will test the effect of rTMS induced modulation (cTBS- inhibitory, iTBS-excitatory, sham) of the cerebellar output on PAS induced plasticity in patients with dystonia and healthy control.
We will also assess the acute effect of the rTMS induced modulation of the cerebellar output on the dystonic symptoms and on the performance at a validated sensorimotor adaptation task. This will be done by double blind post-hoc scoring of the dystonia (BFM or TWSTRS) on standardized videorecording and measurement of the performance at the task after each rTMS session (cTBS, iTBS, sham).
Finally, we will assess the variation of PAS effect on other parameters reflecting cortical excitability after each rTMS session (cTBS, iTBS, sham).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dystonia
Keywords
Cerebellum, Cortical plasticity, Sensorimotor adaptation, Dystonia, Cerebral Palsy, Transcranial Magnetic Stimulation, and
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
120 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Primary cervical dystonia Patients
Arm Type
Experimental
Arm Title
Primary upperlimb Dystonia Patients
Arm Type
Experimental
Arm Title
Secondary Cervical or Upperlimb Dystonia due to cerebral palsy
Arm Type
Experimental
Arm Title
Healthy volunteers
Arm Type
Other
Intervention Type
Other
Intervention Name(s)
Transcranial magnetic stimulation
Intervention Description
Transcranial magnetic stimulation (PAS and rTMS)
Primary Outcome Measure Information:
Title
Comparison of MEP0/MEP10 and MEP0/MEP30 values obtained after sham, cRTBS or iTBS of the cerebellum.
Description
The effect of rTMS induced modulation of the cerebellar output on the PAS induced plasticity will be assessed by measurement of the size variation of a 1mV test motor evoked potential (which reflect cortical excitability) before (MEP0) and 10 and 30 minutes (MEP10 and MEP30) after PAS. The primary outcome measure will be the comparison of MEP0/MEP10 and MEP0/MEP30 values obtained after sham, cRTBS or iTBS of the cerebellum.
Time Frame
6 weeks
Secondary Outcome Measure Information:
Title
Variation of the appropriate dystonic clinical score (depending on the type of dystonia) after each rTMS session (cTBS, iTBS, sham).
Description
The effect of rTMS induced modulation of the cerebellar output on dystonic symptoms will be assessed by the variation of the appropriate dystonic clinical score (depending on the type of dystonia) after each rTMS session (cTBS, iTBS, sham).
Time Frame
6 weeks
Title
Measurement of number of errors, mean time to reach the target after each rTMS session (cTBS, iTBS, sham).
Description
The effect of rTMS induced modulation of the cerebellar output on the performance at the sensorimotor adaptation task will be assessed by measurement of number of errors, mean time to reach the target after each rTMS session (cTBS, iTBS, sham).
Time Frame
6 weeks
Title
Measurement of the variation of the motor threshold, intracortical inhibition and intracortical facilitation after each rTMS session (cTBS, iTBS, sham).
Description
The effect of rTMS induced modulation of the cerebellar output on other parameter reflecting cortical excitability will be assessed by measurement of the variation of the motor threshold, intracortical inhibition and intracortical facilitation after each rTMS session (cTBS, iTBS, sham).
Time Frame
6 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria
All subjects
Age >18 years and < 70 years
Normal physical and neurological examination, except for dystonia (when present)
No treatment with botulinum toxin during the last three months
No treatment altering the cortical excitability
Agreement to use a medically acceptable method of contraception throughout the study for female of childbearing potential
Primary focal dystonia group
Patients with cervical and/or upper limb dystonia
No cause of secondary dystonia
Secondary dystonia group
• Cervical dystonia and/or upper limb dystonia History of perinatal anoxia
Exclusion criteria
MMS ≤ 24/30
Current neurological or psychiatric illness other than dystonia.
Individual who is on medication which is known to lower seizure threshold (see lists above), or who has a pacemaker, an implanted medical pump, a metal plate, a metal plate or metal object in the skull or eye (for example after brain surgery) will be excluded
Uncontrollable medical problems not related to dystonia such as; cardiopulmonary disease, severe rheumatoid arthritis, active joint deformity of arthritic origin, active cancer, or renal disease
Previous history of seizure(s) or current active epilepsy
Pregnancy, breast feeding women and women who are of childbearing age and not practicing adequate birth control.
Patients legally protected
Patients who are not enrolled at social security
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Emmanuel Roze, MD, PhD
Phone
+331 42 16 15 48
Email
emmanuel.roze@psl.aphp.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Emmanuel Roze, MD, PhD
Organizational Affiliation
Institut National de la Santé Et de la Recherche Médicale, France
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Asha Kishore, MD
Organizational Affiliation
Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST)
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Margherita Russo, MD
Organizational Affiliation
Policlinico G . Martino
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hpôpital Pitié Sapétrière - U 975 Plate forme " Pole Exploration de l'homme : Gait, Equilibrium, Posture, and Movement "
City
Paris
ZIP/Postal Code
75013
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emmanuel Roze, MD
Phone
+331 42 16 15 48
Email
emmanuel.roze@psl.aphp.fr
First Name & Middle Initial & Last Name & Degree
Emmanuel Roze, MD, PhD
12. IPD Sharing Statement
Learn more about this trial
Cerebellum and Cortical Plasticity: the Case of Dystonia
We'll reach out to this number within 24 hrs